Ibio To Participate In Upcoming Healthcare Investor Conferences
Jefferies Global Healthcare Conference
Presentation Date: Thursday, June 4, 2026
Time: 11:40 a.m. ET
Location: Marriott Marquis, New York
A livestream of the event can be accessed link, and a replay of the presentation webcast will be available on the Investor Relations section of the iBio website for 90 days following the event.
Leerink Partners Therapeutics Forum: I&I and Metabolism
Event Dates: July 14–15, 2026
Location: Boston Harbor Hotel, Boston
Dr. Brenner and Mr. Duran will participate in one-on-one investor meetings during the Leerink conference. Preliminary meeting schedules are expected to be available in mid-June.
To request a meeting with Dr. Brenner or Mr. Duran at either conference, please contact ....
About iBio, Inc.
iBio (Nasdaq: IBIO) is a clinical-stage biotechnology developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, cancer, and other hard-to-treat diseases. Combining advanced antibody engineering with AI-driven discovery, iBio is advancing a differentiated pipeline designed to deliver sustained therapeutic effects and address significant unmet medical needs. iBio's mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine. For more information, visit or follow us on LinkedIn.
Contact:
iBio, Inc.
Investor Relations
...
Ignacio Guerrero-Ros, Ph.D., or David Schull
Russo Partners, LLC
...
...
(858) 717-2310 or (646) 942-5604

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment